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Little more thon a year ago, a mummified child from the Saint Louis Science Center was brought to Washington 
University Medical Center as part of a research study that included computed tomography scanning, DNA testing, 
and radiocarbon dating. When study results were announced at the March 1 Sth Science Center news conference, 
media around the world—including ABC's Good Morning America, the Washington Post, and China's Xinhua News 
Agency—were fascinated with the story of this unknown child. Scientific findings showed that the mummy was a 
male infant (age: six to eight months) and lived approximately 2,000 years ago. 
For more information about the child mummy exhibit at the Science Center, visit www.slsc.org. For more informa- 
tion about the Institute's involvement in this research, visit the Electronic Radiology Lob at http://erl.wustl.edu/. 
Photograph by Kimberly Kania, MIR Photography lab. 
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Visit the MIR web site at 
www.mir.wustl.edu 
4 king Tumors, Saving Lives 
Interventional radiologists and 
urologic surgeons use cryoablation— 
a less-invasive, computed tomogra- 
phy-guided technique—to treat 
kidney tumors. 
1 OThe Skinny on Fat 
A collaborative study led by radiol- 
ogists and internists shows that 
magnetic resonance imaging can 
effectively screen abdominal 
fat in obese adolescents. 
12 A Window into the Heart 
Armed with the latest CT and MRI 
technology, a team of radiologists 
and cardiologists provide better 
care for patients with coronary 
artery disease. 
8 Predicting Cervical Cancer 
Treatment Outcomes 
Several studies involving positron 
emission tomography, a valuable 
tool in cancer diagnosis, may 
change treatment modalities for 
patients with cervical cancer. 
2 1 Keeping Tabs on Multiple Sclerosis 
Three investigators discuss a mag- 
netic resonance technique, called 
diffusion tensor imaging, used to 
track tissue damage in patients 
with multiple sclerosis. 
ON THE COVER Radiologist Pamela Woodard and 
cardiologist Benico Barzilai will head one of Missouri's 
first interdisciplinary cardiac imaging groups. 




results are in 
The 2007-2008 resident 
training programs begin on 
July 1. This year, the Institute 
welcomes 18 trainees who 
come from these excellent 
schools: 
• David Geffen School of 
Medicine at the University 
of California, Los Angeles 
• University of Alabama 
School of Medicine 
• Vanderbilt University 
School of Medicine 
• University of Wisconsin 
School of Medicine and 
Public Health 
• University of Iowa Roy J. 
and Lucille A Carver College 
of Medicine 
• Emory University School 
of Medicine 
• Georgetown University 
School of Medicine 
• University of Louisville 
School of Medicine 
• University of Washington 
School of Medicine 
• Indiana University School 
of Medicine 
• Southern Illinois University 
School of Medicine 
• Saint Louis University 
School of Medicine 
• University of Utah School 
of Medicine x 
• The Chicago Medical 
School at Rosalind 
Franklin University of 
Medicine and Science 
• Washington University in 




Jennifer (Jeni) Sprague, 
a student in the Medical 
Scientist Training Program, 
received the 2006-2007 Hugh 
M. Wilson Award for Merito- 
rious Work in Radiology. The 
award honors Mallinckrodt 
Institute's second director 
and is presented as part of 
Washington University in 
St. Louis School of Medicine's 
(WUSM's) commencement 
program. 
Sprague earned an 
undergraduate degree in 
biochemistry (with highest 
honors) at Indiana Univer- 
sity and received a combined 
medical/doctoral degree at 
WUSM. She completed her 
doctoral research in Mallinck- 
rodt Institute's Radiological 
Chemistry Laboratory. 
Under the mentorship of 
Carolyn Anderson, PhD, 
professor of radiology and 
associate professor of 
molecular biology and 
pharmacology, Sprague's 
research combined basic 
science and translational 
research in the evaluation of 
radiopharmaceuticals for 
Researcher Carolyn Anderson (left) in the lab with Jennifer Sprague 
early diagnosis and monitor- 
ing of cancer metastasis 
using positron emission 
tomography (PET). 
As a result of Sprague's 
work involving the radio- 
chemistry, characterization, 
and biological evaluation of 
copper-64, a tracer used 
with PET for cancer imaging, 
her research was published 
in four scientific journals: 
Clinical Cancer Research, 
Nuclear Medicine and 
Biology, Journal of Nuclear 
Medicine, and the Journal of 
Medicinal Chemistry. 
"While performing her 
dissertation research in my 
lab, Jeni had outstanding 
ideas toward the progress 
and direction of her project 
and demonstrated scientific 
maturity well beyond her age 
and experience," says Ander- 
son. "Jeni's insight and 
curiosity have led to some 
very exciting discoveries 
regarding the development 
of novel imaging agents and 
imaging strategies. What 
makes her truly exceptional, 
however, is the combination 
of her scientific and personal 
maturity, profound curiosity, 
and unbelievable organiza- 
tional and time-managemeni 
skills. I have been extremely 
fortunate to have a student 
of such caliber working in 
my group" 
(           1 
Welch speaks at Nobel 
Conference 
Michael Welch, PhD, professor of radiology, of chemistr; 
and of molecular biology and pharmacology, presented an 
overview of "PET imaging using nonstandard radionuclides" 
at the Nobel Conference, Watching Life through Molecular 
Imaging. The conference was held in the Nobel Forum—whe 
the Nobel Prize in Physiology or Medicine is selected—at the 
Karolinska Institute in Stockholm, Sweden. Prior to the Nobt 
Forum, Welch, cochief of Mallinckrodt Institute's Division 
of Radiological Sciences, was keynote speaker at the 1701 
International Symposium on Radiopharmaceutical Sciences 
in Aachen, Germany. 
MALLINCKRODT INSTITUTE OF RADIOLOGY 



















The Institute's diagnostic 
radiology resident/faculty 
team was the big winner— 
for the third time— in the 
Philips Vydareny Imaging 
Interpretation Competition 
at the 55'" Annual Meeting 
f of the Association of Univer- 
: sity Radiologists (AUR). 
Team members: doctors 
Kristopher Cummings, 
Joseph Erinjeri, and Jack 
Jennings-2006-2007 diagnostic 
radiology chief residents; 
^onstantine Raptis-second- 
year resident; Jennifer 
)emertzis, Meghan Lubner, 
nd Sara Rohr-third-year 
residents and the 2007-2008 
liagnostic radiology chief 
residents; Jeffrey Carenza 
fourth-year resident; Daniel 
I'essell, musculoskeletal 




Bayer HealthCare has 
funded a fellowship for 
I research involving contrast- 
| enhanced magnetic reso- 
nance imaging (MRI). Jeffrey 
Brown, MD, professor of 
radiology, director of clinical 
research, and cochief of 
body MRI, will administer 
the one-year fellowship that 
will begin in November 2007. 
For more information about 
' the fellowship and the appli- 
cation process, go to the 
"tfallinckrodt Institute of 
adiology Web site at 
v.mir.wustl.edu. 
2005-2006 diagnostic radiology 
chief resident; Jennifer 
Gould, assistant professor of 
radiology and director of the 
Diagnostic Radiology Resi- 
dency Training Program at 
Mallinckrodt Institute; 
Christine Menias, assistant 
professor of radiology and 
residency program assistant 
director; and Sanjeev Bhalla, 
assistant professor of radiol- 
ogy and residency program 
assistant director. Jennifer Gould, MD, accepts the award from Reed Dunnick, MD, AUR president. 
fl£ .,J* 
In the huddle: (seated, left to right) 
Daniel Wessell, MD, PhD; Christine 
Menias, MD; Sanjeev Bhalla, MD; and 
Jennifer Gould, MD. (Standing, left to 
right) Jennifer Demertzis, MD; 
Constantine Raptis, MD; Kristopher 
Cummings, MD; Joseph Erinjeri, MD, 
PhD; and Sara Rohr, MD. 
WUSM among nation's top schools 
In the 2007 U.S. News & World Report rankings, Washington University in St. Louis 
School of Medicine (WUSM) retained its fourth overall ranking among research-oriented 
medical schools and continues to hold first place in student selectivity (based on college 
grade-point averages and MCAT scores). Among the top schools are Harvard University 
(ranked first); Johns Hopkins University (second); University of Pennsylvania (third); 
University of California, San Francisco (fifth); University of Washington (sixth); Stanford 
University (seventh), Duke University and Yale University (tied for eighth place). 





Using cryoablation to destroy kidney-tumors 
side the procedure room, the patient's computed tomography (CT) 
scan shows a tiny tumor sitting squarely in the middle of his left 
kidney—a challenging spot for resection. Further complicating 
"case is the patient's medical history. Years before, he had 
his right kidney to another tumor, and removing too much 
lis remaining kidney will compromise its function, sen- 
tencing him to a lifetime of dialysis treatment. 
For most patients with early-stage kidney 
tumors, surgery is still the standard of care. But this 
man, like a growing number of others for whom 
surgery is not an option, will undergo a newer, 
less-invasive radiological procedure: cryoablation. 
On the CT image, the two percutaneously 
(through the skin) placed needles appear, 
releasing a liquefied, inert gas (argon) into the 
tumor area. Suddenly, an ice ball forms, enveloping 
the tumor. After 10 minutes of freezing, five 
minutes of thawing with helium gas, and 10 
more minutes of freezing, the procedure 
is complete. 
■Mi 
T" M   T'eeks later, 
I /■ / during the 
1/ 1/ patient's ■    * follow-up 
examination, the 
tumor appeared to 
be totally destroyed, 
says Daniel Brown, 
MD, an interven- 
tional radiologist at 
Mallinckrodt Insti- 
tute who performed 
the cryoablation in 
collaboration with 
urologic surgeon 
Sam Bhayani, MD. 
The two physicians have collabo- 
rated on the 25 cryoablations that 
have taken place at Barnes-Jewish 
Hospital over the past two years. 
Before each procedure, the patient 
CASE 1: Computed tomography (CT) images of a 75-year-old female with a 4 cm tumor in the upper pole of her kidney. Patient is not a good 
candidate for surgery. 
is seen in the Interventional Oncology 
and Urology Clinic at the Washington 
University Medical Center so 
Brown and Bhayani can decide 
together whether to recommend 
surgery or cryoablation. After the 
procedure, the patient 
is seen in the clinic, 
and images are reviewed 
to determine whether 
the tumor has been 
adequately treated. 
"We have a well- 
formed cooperative 
relationship that has let 
us deliver the best care 
to the patients," says 
Brown, associate pro- 
fessor of radiology and 
of surgery. "This is an 
interdisciplinary effort," 
adds Bhayani, assistant 
professor of urology 
and of surgery. "The 
patients benefit because 
they get an opinion 
from an expert in kidney 
surgery and from an 
expert in interventional 
oncology." 
The procedure 
Brown and Bhayani have 
pioneered at Washing- 
ton University Medical 
Center, a national 
leader in ablation, 
is still considered investigational 
but has so far had very promising 
results. Papers published recently 
by three other medical centers— 
Johns Hopkins, the Mayo Clinic, 
and Wayne State University 
—showed only a handful of recur- 
rences among patients treated by 
cryoablation during the first year 
of follow-up care. 
"We need to eliminate those 
recurrences before we can consider 
this as a replacement therapy for 
surgery, and we're still a long way 
from that. We also need to track its 
long-term outcome," says Brown. 
"But in the meantime, for patients 
who are not surgery candidates, 
this is a wonderful option." 
Background of the Cancer 
Renal cell carcinoma is a fairly 
rare tumor: seventh or eighth most 
common among men and twelfth 
most common among women. 
In the United States, some 35,000 
new cases are diagnosed each year, 
most of them among people in their 
50s. While there is a weak link 
between smoking and the develop- 
ment of this cancer, the cause is 
largely unknown. The number of 
patients with kidney cancer overall 
also is growing, for reasons that 
are likewise unclear. 
Above: Doctors Sam Bhayani (left) and Daniel Brown 
Left: Renal cell cancer 
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CASE 1: Images taken during the procedure show an ice ball surrounding the tumor. 
"We have identified some of 
the genetics behind renal cell 
carcinoma," says Bhayani, "but we 
don't know yet why certain genes 
mutate, causing these cancers to 
form. So although we've made 
great strides, we don't have the 
full information as yet." 
Some 30 years ago, before the 
advent of CT scans and magnetic 
resonance imaging, these tumors 
were nearly always discovered 
when patients found blood in 
their urine or felt a pain in their 
side. By then, the masses were 
large, up to eight or nine centimeters 
in size, and surgical 
removal was the 
only option. 
Bhayani's study, 
published in the 
Journal of Urology in 
2006, shows that this 
picture has changed 
dramatically. With 
new imaging technolo- 
gies, some 80 percent 
of patients who were 
recently diagnosed 
with kidney cancer at 
Barnes-Jewish Hospital 
had no symptoms, 
and their renal tumors were picked 
up incidentally on CT scans that 
were taken for other reasons. 
These masses may be tiny (1 to 4 
centimeters in size), which makes 
them good candidates for ablation. 
The Cryoablation Procedure 
For years, radiofrequency (RF) 
ablation—the heat-based cousin 
of cryoablation—has been used 
effectively to fight liver, lung, and 
bone tumors. As in cryoablation, 
radiologists insert needles into the 
tumor, but these needles carry a 
current that heats up the tissue and 
kills the cells. The problem is that 
RF ablation is painful and requires 
significant sedation or general 
anesthesia. Cryoablation, which is 
much less painful, works better 
on kidney cancers and also on 
patients for whom anesthesia is 
risky, including those with poor 
heart function or damaged lungs 
because of smoking. 
Age also is a factor. For older 
patients, cryoablation may work 
well, even if its long-term results 
should prove to be slightly less 
effective than surgery. "If the 
cancer comes back in twenty 
years and the patient is seventy- 
five or eighty, then the recurrence 
may not be as emotionally difficult 
for the patient," says Bhayani. 
Cryoablation—also used by 
urologists in laparoscopic procedures 
—involves CT guidance, slender 
needles, and gases. Once the 
needles are inserted through the 
skin and into the kidney, they 
deliver argon gas into the tumor. 
The temperature at the needle tip 
reaches minus 140 degrees, and ice 
begins forming instantly. Away 
from the needle tip, the temperature 
rises somewhat, but a range of minus 
20 to minus 40 degrees is still lethal 
to tumors. 
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I: These images taken after cryoablation show an absence of contrast enhancement of the tumor—a finding compatible with 
a successful procedure. 
MALLINCKRODT INSTITUTE OF RADIOLOGY 
• Is the ice ball surrounding the 
tumor? Up to eight needles can be 
used for a larger area of "cell kill." 
"As you put more needles in, it 
actually becomes a multiplying 
rather than an additive effect," says 
Brown. "The needles synergize, 
and the ice ball gets bigger." 
The patient stays in the hospital 
overnight in case of any bleeding 
complications. With a highly 
vascular organ like the kidney, there 
is always the chance of a small vein 
oozing blood, which could poten- 
tially require a blood transfusion. 
Pros and Cons of 
Treatment Options 
Surgical excision has a key 
advantage over cryoablation for small 
kidney tumors: Surgeons can cut 
out the mass and send the marginal 
cells to pathology for analysis, to 
see whether all the cancer was 
removed. Since kidney cancer is 
categorized into five subtypes, each 
with its own characteristics, cellular 
analysis also can tell doctors how 
aggressive the tumor was, which 
will give them prognostic data. 
With cryoablation, radiologists 
cannot rely on sending a specimen 
to pathology. Still, the results to 
date indicate that the procedure is 
remarkably effective. Preliminary 
national data shows an effective- 
ness rate of 93 percent or 94 
percent. Of the 25 patients treated 
at Barnes-Jewish Hospital, only 
two have had any residual tumor. 
Both patients were successfully 
treated at a second visit. 
Once kidney cancer has 
metastasized, it is uniformly fatal, 
so physicians want to catch any 
recurrence early on. Radiological 
• Kidney Cancer Association: 
www.kidneycancer.org 
• National Cancer Institute: 
http://cis.nci.nih.gov/ 
• American Cancer Society: 
www.cancer.org 
follow-up is crucial. After undergo- 
ing cryoablation, patients return to 
Mallinckrodt Institute for CT scans, 
taken at one month, then three to six 
months, and thereafter at regular 
intervals indefinitely. Surgical 
patients also require follow-up care, 
though less frequently. 
Overall, cryoablation as a treat- 
ment for kidney tumors means one 
more option for patients, say both 
physicians. "If you are going to offer 
the full range of treatments for 
patients with renal cell carcinoma, 
cryoablation is an important part of 
their decision making," says Brown. 
"Ultimately, patients benefit because 
they can choose among various 
options—and all the options are 
effective," says Bhayani. EH 





an imaging method 
developed at Mallinckrodt 
Institute of Radiology (MIR) in 
the early 1970s, has become a 
valuable tool in cancer imaging. 
Malignant tumors tend to devour 
more sugar (glucose) than do benign 
tumors. PET imaging of cancer typi- 
cally involves the use of a radioactive 
glucose-based analog, or compound, 
called fluorodeoxyglucose (FDG). 
Ultimately, abnormal FDG uptake 
appears as "hot spots" (brighter 
areas) on PET images. In some 
types of cancers, it has been shown 
that if a PET scan is done prior to 
chemotherapy and again midway 
through treatment, changes in 
glucose uptake can be tracked to 
determine if the tumor is responding 
to therapy or if the treatment plan 
should be changed. The patient can 
then be spared the adverse effects 
of a therapy that is not affecting the 
cancer. Now studies have shown 
that PET is useful in predicting 
relative survival rates for patients 
with cervical cancer. 
Perry Grigsby, MD, a radiation 
oncologist and director of the 
Brachytherapy and microRT 
treatment centers at the Siteman 
Cancer Center, says glucose uptake 
may vary more in cervical cancers 
than in other types of cancers. 
Radiation oncologist Perry Grigsby 
Glucose uptake appears to be 
greater in cervical tumors that are 
not responding to treatment, inde- 
pendent of the size of the tumor. 
In Grigsby's research, each cervical 
tumor was assigned a maximal 
standardized uptake value (SUVmax, 
and referred to in this article as 
SUV) based on how much glucose 
was used: the higher the SUV, the 
higher the risk of lymph node 
metastases, and the lower the 
patient's survival rate. 
STUDY FINDINGS 
The mean SUV was 10.2 in 
the first study group of 96 patients. 
Patients whose tumors had an 
SUV below the mean had a five-year 
survival rate of 71 percent; those 
above, a 52 percent chance of 
surviving five years without 
a recurrence. 
"By the time an article was 
published in the April 2006 issue 
of Gynecological Oncology, we had 
doubled the number of patients 
in the study, and it was clear that 
Left: PET/CT image shows the cervical cancer (solid 
white area) and radiation doses (brightly colored areas). 
there were really three demarca- 
tions in the data," says Grigsby, a 
professor of radiation oncology, 
of radiology, and of obstetrics and 
gynecology. "Based on a statistical 
model, we assigned two hundred 
and eighty-seven patients into three 
separate survival-rate groups." 
According to Grigsby, at the 
patients' five-year follow-up exami- 
nations, the results were remarkable: 
• 95 percent of patients with an 
SUV below 5.2 were disease-free. 
• Survival rate for patients with an 
SUV between 5.2 and 13.3 was 70 
percent. 
• 44 percent of patients with an 
SUV over 13.3 were disease-free 
at five years. 
Follow-up examinations at 
seven to eight years showed more 
marked differences in the patients 
who were disease-free: 
• 90 percent of patients with an 
SUV below 5.2, 
• 75 percent with an SUV between 
5.2 and 13.3, 
• 10 percent with an SUV over 13.3. 
Grigsby's research also showed 
there was a great deal of hetero- 
geneity within the cervical tumors. 
A tumor's high SUV score did not 
apply to the whole tumor, only a 
part of it. Grigsby and fellow 
researchers are attempting to identify 
which areas of the cervical tumor 
are high in glucose uptake and 




Another project in the works 
is examining the genes responsible 
for high glucose uptake. The research 
team identified some genetic changes 
in tumor biopsies; they want to see 
if those results are consistent across 
a larger group. 
STATISTICS 
CERVICAL CANCER STATISTICS 
"■ This year in the United States, 
approximately 11,150 cases of 
invasive cervical cancer will 
be diagnosed. 
In 2007, some 3,600 women in 
the United States will die from 
cervical cancer. 
The death rate from cervical 
cancer continues to decline by 
nearly four percent each year. 
Half of the women diagnosed 
with cervical cancer are between 
the ages of 35 and 55. 
Around 20 percent of women 
with cervical cancer were 
diagnosed at age 65 or older. 
The overall (all stages combined) 
five-year survival rate for women 
diagnosed with cervical cancer 
is about 72 percent. 
Before Pap smears (also called 
Pap test, Papanicolaou smear, or 
cervical smear) were in general 
use, cervical cancer was the 
second leading cause of cancer- 
related deaths in the world. 
In developing countries, cervical 
cancer still has a 50 percent 
mortality rate. 
For more information, 
go to the American Cancer Society 
Web site: www.cancer.org. 
FOCAL SPOT, SPRING 2007 
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Cervical Cancer Treatment Outcomes 
HETEROGENEITY OF FDG UPTAKE IN PRIMARY CERVICAL CANCERS 
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They also are looking at the 
role of human papilloma virus (HPV) 
in those tumors. "We know that 
ninety-nine percent of cervical 
cancers are caused by HPV," says 
Grigsby. "Once the patient is diag- 
nosed with cancer, physicians typically 
concentrate on curing the cancer, 
not the HPV. There's no consensus 
as to whether that's the right decision. 
When the cancer starts to grow, no 
one has asked what the current 
role of HPV is in this disease." 
Grigsby is particularly interested 
in the virus because of the other 
HPV-related malignancy—anal can- 
cer. "Both cervical and anal can- 
cers are of the squamous-cell types 
and are caused by HPV," he says. 
"We've been using PET to study 
cervical cancer for nine years, and 
studies of anal cancer in tandem 
with cervical cancer have been 
active for the last two years. The 
findings are strikingly similar. 
There's a good chance that any 
changes in treatment modalities 
that come out of this study will 
apply to both types of cancer." 
"The SEER report card [Surveillance Epidemiology and End 
Results, a source of information on cancer incidence and 
survival in the United States] published by the National 
Cancer Institute still ranks cervical cancer as third in the 
average years of life lost from cancer deaths, ranking behind 
childhood cancers and testicular cancer, which tends to affect 
younger, rather than older, men." —PERRY GRIGSBY, MD 
PET POTENTIAL 
Farrokh Dehdashti, MD, a 
nuclear medicine physician at MIR, 
expands on clinical PET studies: 
"As yet, there are no standards in 
place for changing a course of 
treatment based on a tumor's high 
FDG uptake, as measured by SUV; 
thus, we watch these patients 
closely and use PET following 
completion of therapy to assess 
response to therapy and to detect 
early recurrence." 
Dehdashti, a professor of 
radiology, is especially encouraged 
by her research involving the 
measurement of tumor oxygenation 
in patients with cervical cancer. 
"A special hypoxic marker measures 
the oxygenation of the tumor," 
she says. "We know that well 
oxygenated tumors respond better 
to radiation as compared to low 
oxygenated [hypoxic] tumors. 
Our initial study involved fourteen 
patients with cervical cancer. 
Now, we have completed the study 
of thirty-eight patients and found 
similar results." 
10 MALLINCKRODT INSTITUTE OF RADIOLOGY 
The PET hypoxic tracer first 
used by Dehdashti was Copper- 
60-ATSM (Cu-60-ATSM), which, 
because it has a 24.5 minute 
half life, must be produced on a 
nearby cyclotron. This study was 
performed with institutional 
approval and was done at Washing- 
ton University School of Medicine 
with the availability of the three 
cyclotrons housed at Mallinckrodt 
Institute. In order to make this 
radiopharmaceutical more widely 
available, the radiochemistry team 
wanted to produce Cu-64-ATSM. 
Since Cu-64 has a 12.7 hour half 
life, it can be transported to medical 
Nuclear physician Farrokh Dehdashti 
centers that are conducting 
PET studies but do not have an 
in-house cyclotron. 
But first, the research team 
had to determine if the quality of 
PET images performed using 
Cu-64-ATSM was comparable to 
that of Cu-60-ATSM. In order to 
study Cu-64-ATSM, it was necessary 
to obtain an Investigational New 
Drug (IND) approval from the 
United States Food and Drug 
Radiochemist Jason Lewis 
Administration (FDA)—which 
was obtained with the help of the 
Development of Clinical Imaging 
Drugs and Enhancers (DCIDE) pro- 
gram at the National Cancer Institute. 
Jason Lewis, PhD, an assistant 
professor of radiology, obtained 
the toxicology and pharmacology 
data for Cu-64-ATSM, which was 
required for approval of the IND 
by the FDA. Dehdashti and Barry 
Siegel, MD, a professor of radiology 
and chief of the Institute's Division 
of Nuclear Medicine, have com- 
pleted a study that compared PET 
images using both tracers. If there 
is no clear advantage for using 
Cu-60, then the Cu-64 tracer can be 
transported to other study centers, 
which will greatly expand cervical 
cancer research. ED 
Editor's note: Doctors 
Dehdashti, Ghigsby, Lewis, 
and Siegel recently were 
invited to the National Cancer 
Institute to discuss their role 
in developing a multicenter 
trial for Cu-64. 
EVELOPMW 
PET RADIONUCUDE DEVELOPMEPMENT AT MIR 
The Cu-ATSM hypoxia selective radiopharmaceutical used in the 
cervical cancer studies at Washington University School of Medicine 
were developed in Mallinckrodt Institute's Radiological Chemistry 
Laboratory as part of the Radionuclide Resource for Cancer Applica- 
tions, a National Cancer Institute-sponsored program. The following 
MIR scientists are involved in this program: 
• Jason Lewis, PhD, an assistant professor of radiology and codirector 
of the microPET imaging facility 
• Michael Welch, PhD, a professor of radiology and of chemistry and 
cochief of the Institute's Division of Radiological Sciences 
• Thomas Voller, research laboratory supervisor. 
FOCAL SPOT, SPRING 2007 
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■NTURE FOR RADIOLOGY AND CARDIOLOGY 
I 1 promise quicker diagnosis of hidden health threats 
in some patients. At Washington University in St. Louis, a 
partnership that combines the top-level expertise of radiologists 
and cardiologists with the cutting-edge technology of computed 
tomography (CT) and magnetic resonance imaging (MRI) 
will provide a greater understanding of coronary artery disease. 
This joint venture will create 
a new imaging group, an interdisci- 
plinary team of radiologists and 
cardiologists that will be part of 
Mallinckrodt Institute of Radiology's 
Cardiothoracic Imaging section. 
The cardiac imaging staff will be 
headed by Pamela Woodard, MD, 
an associate professor at Mallinck- 
rodt Institute, and Benico Barzilai, 
MD, a professor in the Department 
of Medicine's Division of Cardio- 
vascular Disease. The partnership 
is one of a handful of such interdis- 
ciplinary efforts in the country and 
the only one in Missouri, according 
to Woodard. 
The cardiothoracic imaging 
group will specialize in cardiac CT 
angiography, using a CT scanner to 
produce high-resolution, three- 
dimensional images of coronary 
arteries and cardiac anatomy and 
using MRI to assess cardiac 
morphology and function. "One 
exciting aspect of this program is 
the new CT technology that allows 
us to acquire volumetric data 
covering the heart at every phase 
of the cardiac cycle, very rapidly," 
extols Woodard. "The technology 
gives physicians a noninvasive tool 
to view cardiac function." 
The advent of the 64-slice CT 
scanner in 2003 opened a wealth of 
new applications in cardiac imaging 
but also raised questions—some 
would say controversy—about the 
applicability and best use of the 
new technology. Radiology centers 
large and small have been snapping 
up the $1.5 million machines in the 
hope of attracting paying customers 
who, although they have no symp- 
toms, want to know more about 
their own heart health. This joint 
venture advocates a measured 
approach and lets patient needs 
dictate the role of technology. 
Left: Three-dimensional, surface-rendered coronary 
CT angiogram shows two saphenous bypass grafts 
(white arrows). Red arrow points to a stenosis. 
The Radiology Group: (front row, left to right) 
Doctors Fernando Gutierrez and Andrew Bierhals; 
(second row, left to right) Doctors Pamela Woodard, 
Cylen Javidan-Nejad, and Sanjeev Bhalla. Not shown: 
Vamsidhar Narra. 
The speed and resolution of 
these newest CT scanners has 
altered the diagnostic landscape. 
The 64-slice CT scanner takes 64 
images (in scanner nomenclature, 
these are known as slices) in a 
single revolution around the tube 
in which the patient lays supine 
for the exam. The duration that 
patients must hold their breath 
during the exam (known as the 
"breath-hold") takes only a few 
seconds. The resulting images are 
richly detailed, showing the intrica- 
cies of the cardiovascular system, 
including the exterior of coronary 
arteries and vessels. In contrast, 
invasive techniques can only reveal 
what is going on in the interior of 
the structures. 
Cardiac CT angiography is 
evolving into a powerful tool in the 
battle against one of the deadliest 
threats to heart health—coronary 
artery disease. Sudden cardiac 
deaths, primarily from heart attack 
and stroke, number about one-half 
million in the United States. 
The Partnership 
RADIOLOGY 
Pamela Woodard, MD, associate professor 
Sanjeev Bhalla, MD, assistant professor 
Andrew Bierhals. MD, MPH, instructor 
Fernando Gutierrez, MD, professor 
Cylen Javidan-Nejad, MD, assistant professor 
Vamsidhar Narra, MD, associate professor 
CARDIOLOGY 
Benico Barzilai, MD, professor 
Tillman Cyrus, MD, instructor 
Ibrahim Saeed, MD, assistant professor 
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o order a cardiac CT 
■ cardiac MRI scan, 
call CENTRAL SCHEDULING 
at (314) 362-71 11. For same 
day add-ons or for a physician 
consultation regarding an exami- 
nation, page (314) 663-1010. 
Scheduling of these examinations 
must be done by a physician or 
by the physician's office staff. 
The Cardiology Group: (left to right) Doctors Ibrahim 
Saeed, Benico Barzilai, and Tillman Cyrus 
Most of the deaths, and many 
more incapacitating heart attacks, 
result from coronary artery dis- 
ease. One reason heart attacks and 
strokes are so feared among 
healthy Americans is because they 
frequently occur in people who 
appear healthy and without warn- 
ing or symptom. The death in 1982 
of marathon-runner Jim Fixx drew 
national attention to the lurking 
nature of the disease. Fixx was 
felled by a massive heart attack at 
age 52; his autopsy revealed coro- 
nary occlusion in three arteries. 
Although he had a family history of 
heart disease, Fixx had no symptoms 
and, in part due to his level of exer- 
cise, believed he was in excellent 
health. Cardiac CT angiography 
may lead to earlier diagnosis and 
treatment of these silent threats to 
heart health. 
Coronary blockages are caused 
by atherosclerosis, as fatty material 
collects and thickens along the 
interior walls of arteries. This hard 
substance, called plaque, retards 
blood flow through the artery and 
also can break off in pieces, caus- 
ing a heart attack or a stroke. And, 
blood clots may attach onto plaque 
material, further restricting blood 
flow and also presenting the possi- 
bility of breaking off and causing a 
stroke or a heart attack. 
Some people experience chest 
pain as a result of atherosclerosis; 
tragically for many, there are no 
symptoms before the disease 
causes death. For those who do 
have symptoms, the "gold stan- 
dard" of screening techniques 
remains cardiac catheterization. 
In this procedure, the patient is 
first injected with a contrast agent. 
Then the cardiologist inserts a 
guidewire, and over that a catheter, 
into a major vein in the groin. As an 
X ray views the heart, the physician 
directs the catheter into the arteries 
surrounding the heart, using it to 
introduce additional contrast agent 
to create more detailed X-ray images. 
The advantage of the cardiac 
catheterization is the ability to 
combine diagnosis and treatment 
in one procedure. If the degree of 
blockage is severe, a different type 
of catheter can be placed in the 
vessel and the cardiologist can 
insert a balloon that is used to 
destroy the plaque and clots by 
applying pressure into the balloon 
and, thereby, against the walls of 
the artery. Stents and other thera- 
peutic devices can be inserted 
through the catheter, if needed, 
to give temporary or permanent 
support to the artery walls. 
MALLINCKRODT INSTITUTE OF RADIOLOGY 
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Radiologists and cardiologists 
agree there is a place at the diagnos- 
tic table for cardiac CT angiography, 
but they have yet to decide which 
patients would most benefit. Because 
30 to 40 percent of cardiac catheter- 
izations do not show any blockage, 
there is great interest in determining 
a priori whether a particular patient 
should have the less-invasive CT 
procedure as an initial screening. 
Barzilai acknowledges that 
many unknowns must be addressed. 
"On the one hand, there is the ques- 
tion of screening an asymptomatic 
patient," he says. "If we find some 
blockage, there may be some pres- 
sure to do something about it, even 
if it is minor. On the other hand, 
we aren't really sure what would 
happen to that type of patient if 
they were never evaluated." 
For now, according to 
Woodard, the test is an excellent 
alternative for people with atypical 
chest pain, inconclusive stress tests, 
and chronic chest pain. Some 
patients will indeed need to go 
directly to cardiac catheterization. 
Others may have noncoronary 
cardiac disease that the CT option 
will reveal in great detail, leading to 
appropriate and targeted treatment. 
"Cardiac CT angiography can 
also help us determine the effect 
of blockage on blood flow, and that 
will help us choose the best treat- 
ment option," says Barzilai. "If 
patients have a less-than-nfty percent 
blockage, visible on CT, without 
obstruction of blood flow, then we 
can treat them with medicine." 
Cardiac MRI also will play a role 
in this joint venture. A cardiac-gated 
version of MRI has been available 
since the late 1980s; however, new 
developments occur daily. Cardiac 
MRI, long used for anatomic imag- 
ing, is now the reference standard 
for ventricular function. 
"Newer delayed con- 
trast-enhanced techniques 
can show the exact size 
and location of myocardial 
infarction unlike any 
other test," says Woodard. 
"The same technique can 
be used for characterizing 
cardiomyopathies not 
caused by infarction and 
may provide insight into 
the etiology of a malfunc- 
tioning heart." Techniques 
also are available to assess 
the extent of valve disease 
and to provide information 
about whether a heart 
valve should be replaced. 
Both physicians are 
certain of one thing: The 
joint venture will lead to 
better decision making and 
optimal application of the 
new technology. They are 
proud of their role in pro- 
moting cooperation 
between their disciplines. 
"I hope we will set a bench- 
mark for other institutions," 
says Woodard. "Patient 
care is paramount, not 
who owns the equipment." 
Barzilai emphasizes 
the benefits of the 
approach in teaching 
young physicians. "I'm 
excited that I'll have 
cardiology fellows sitting 
next to radiology fellows, 
treating the same patient. 
The two disciplines bring 
different thought processes 
to the same table. I've 
always believed it's easier 
to collaborate with other 
departments here at 
Washington University than 
at other places. I do it on a daily 
basis. It is one of the strengths of 
our institution." fSM 
Top: This coronary CT ongiogram shows a stenosis 
(arrow) in the distal right coronary artery (RCA). 
Bottom: Delayed contrast-enhanced short axis 
cardiac MR image demonstrates an inferoseptal 
subendocardial infarction (arrow) of the 
left ventricle. 
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USING MRI TO FIGHT TEENAGE OBESITY 
^^* I -a by Anne Kessen Lowell 
esearchers at Mallinckrodt Institute are hunting for new 
and effective ways to assess life-threatening risks to 
adolescents from obesity, and they are forming partner- 
ships with pediatric diabetic specialists and nutrition 
experts to help these impressionable youngsters lead 
healthier lives. One key to improving long-term health 
of overweight teenagers is to understand the location 
of fat within the abdomen. Magnetic resonance imaging 
(MRI) turns out to be an excellent tool to map the composition of 
abdominal fat—external (also called subcutaneous) and internal 
(or visceral). Visceral fat poses greater danger to internal organs 
and is associated with diabetes, heart disease, and nonalcoholic 
fatty liver disease. 
arilyn Siegel, 
MD, professor of 
radiology and of 
pediatrics, is at 






the March 2007 
issue of the jour- 
nal Radiology, 
Siegel described 
her significant work using MRI 
to assess the distribution of 
fat in obese preadolescents 
and adolescents. 
MRI had been proven effec- 
tive for measuring body fat in 
adults, but only a few studies 
had been done in children 
(defined as ages six to 11 years) 
and adolescents (ages 12 to 19 
years). In terms of long-term 
health and the likelihood of 
developing serious disease, there 
is bad fat and there is really 
bad fat. External fat is easy to 
see; we even give it names such 
as "love handles" or "spare 
tire." But internal fat, deep 
inside the body and surrounding 
abdominal organs, is much 
harder to assess and much more 
dangerous to an individual's 
health. "Since so many serious 
illnesses are correlated with intra- 
abdominal fat, it is critical to find 
an accurate way to measure it," 
says Siegel. 
Although causality remains 
a mystery, the measure of intra- 
abdominal fat in teenagers is a 
marker for a future beset by serious 
complications. The obesity rate 
among young people is skyrocketing, 
and pinpointing the presence of 
As an Armed Forces Institute of Pathology Distinguished Scientist, Marilyn Siegel, MD, spent six months in Washington, 
DC, studying the correlation between abnormal radiological images and their underlying pathological processes. 
visceral fat may help to develop 
effective prevention through diet 
and exercise programs that literally 
get beyond the surface. 
"We set out to find a fast, reliable, 
and safe technique to measure fat 
in children. Different options had 
been tried in the adult population 
but not in a pediatric population. 
We wanted to see if we could 
improve accuracy and reduce 
errors that tend to occur in non- 
radiological evaluations," says Siegel. 
MEASURING BODY FAT 
The current standard evaluation 
to estimate total body fat is anthro- 
pometry, a physical examination 
that measures circumference of the 
waist and abdomen, height, and 
body mass index (BMI). Anthro- 
pometry, when performed by 
well-trained practitioners, may 
yield an accurate measurement 
of total fat. But the potential for 
error is high if the practitioners 
lack training. 
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Another reliable method for 
determining total body fat is dual 
X-ray absorptiometry (DXA). 
Although DXA is accurate for 
estimating body fat, this technique 
requires exposure to ionizing 
radiation. In addition, both DXA 
and anthropometry share a disad- 
vantage: Neither test can give a 
breakdown between subcutaneous 
fat and the more harmful 
intra-abdominal fat. 
Siegel collaborated with 
experts at Washington University 
to measure total and intra-abdomi- 
nal fat distribution in adolescents. 
In this study, 30 adolescents had fat 
tissue measurements taken by single- 
section and whole abdominal, 
multi-section MRI. The study's 20 
boys and 10 girls were between the 
ages of 10 and 18: 
• Nine were overweight but did not 
have diabetes. 
• 10 had Type 2 diabetes and were 
overweight. 
• 11 were normal weight and did 
not have diabetes. 
The single-section and 
multi-section MR measurements 
were compared and tested for 
correlations with anthropometric 
S 
Magnetic resonance (MR) image—involving True-FISP (Fast Imaging with Steady Precession, a technique using a fully 
balanced gradient waveform)—of a 10 year-old, overweight girl: abdominal MR image (upper left), total abdomen 
(upper right), and subcutaneous fat (lower left) and visceral fat (lower right) regions are segmented from the MR image. 
and DXA measurements. The soft- 
ware that made the MR analysis of 
fat distribution possible was devel- 
oped in the Electronic Radiology 
Laboratory at Mallinckrodt Institute. 
CLINICAL 
Marilyn Siegel, MD, professor of radiology and of pediatrics 
Neil White, MD, CDE, professor of pediatrics 
ANALYSIS 
Kyongtae Bae, MD, PhD, associate professor of radiology 
Charles Hildebolt, DDS, PhD, associate professor of radiology and 
adjunct associate professor of anthropology 
Cheng Hong, PhD, MD, research associate 
"The signal intensity of fat pixels 
is higher than that of muscle and vis- 
ceral organ pixels," explains Siegel. 
"We can use MRI to separate and to 
measure images of subcutaneous 
and visceral fat and to calculate the 
amount of each type as a percent- 
age of total abdominal area." 
The study produced encourag- 
ing results and suggests that MRI 
can play a leading role in the fight 
against childhood obesity. Fat 
measurements using MRI— 
both single-section and whole- 
abdominal, multi-section imaging— 
strongly correlated with 
anthropometric and DXA calcula- 
tions. Even better, the single- 
section examination, which takes 
just a few seconds, proved to be as 
accurate as the multi-section exam- 
ination for characterizing body fat. 
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Formula for calculating body mass index (BMI): Weight (pounds) * height (inches)2 x 704.5=BMI. 
While all study volunteers had simi- 
lar fat distribution patterns with a 
predominance of fat in the tissues 
of the abdominal wall, the total 
amount of fat varied. Overall fat 
volume was highest in the diabetic, 
overweight adolescents. 
"Now we have a safe, accurate, 
and fast screening tool. Speed is an 
important factor when working 
with young patients," says Siegel. 
"It's difficult to keep them immobile 
for a lengthy examination." 
FORGING PARTNERSHIPS 
Washington University's lead- 
ership in the study and treatment 
of obesity-related illness is leading 
to some exciting partnerships 
between radiologists and internists. 
Mallinckrodt Institute researchers 
are contributing creative thinking 
about the applicability of MRI and 
ultrasound; University investigators 
and clinicians bring knowledge and 
sensitivity to patients (especially 
younger ones) as well as the nuances 
of treating a disease with a large 
behavioral component. 
IK UI DISEASE 
In a separate study involving 
adolescent obesity, Siegel is 
collaborating with other Wash- 
ington University researchers 
to determine if ultrasound—an 
inexpensive, readily available, 
noninvasive technology—is a 
viable tool for diagnosing non- 
alcoholic fatty liver disease 
(NAFLD). Little is understood 
about the cause of NAFLD, but 
most specialists agree that it is 
closely linked to increasing 
rates of obesity. 
"There is great concern 
about the increasing prevalence 
of NAFLD in children," says 
Siegel. "NAFLD has been 
reported to affect twenty-three 
percent of overweight children. 
Yet they may be completely 
asymptomatic until the liver is 
severely damaged." 
Not all cases of NAFLD 
result in symptoms or other 
problems, and the course of the 
disease is being investigated in 
both adults and children. Until 
now, the recommended test for 
detecting NAFLD has been 
proton magnetic resonance 
spectroscopy, an expensive 
technique requiring specialized 
equipment and expertise. 
Siegel reports that in her 
study of 28 overweight adoles- 
cents, ultrasound was a reliable 
tool for diagnosing moderate to 
severe NAFLD. However, she 
concludes that additional studies 
to detect mild NAFLD are needed. 
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Siegel and the research team 
are passionate about making a 
difference in young people's lives. 
"If we successfully monitor the 
progress and effectiveness of 
different strategies, we can keep 
children and teenagers from 
becoming patients in the liver 
transplant program and in the 
cardiac catheterization and renal 
dialysis labs. It's important to 
help them make the connection 
between being overweight and 
developing a life-threatening 
disease," observes Siegel. 
"Their mantra has become, 
'I'm too young for that; I won't get 
sick.' But in St. Louis, in Missouri, 
in the United States, young people 
are becoming very ill as their 
health falls prey to obesity," she 
adds. "We need to help these kids, 
and their parents, to recognize the 
dangers and to help them take 
action. The MRI procedures we 
have developed are potentially 
useful in many clinical and 
research applications, including 
planning patient management, 
monitoring therapeutic interven- 
tions, and implementing multicenter 
clinical trials." EH 
OVERWEIGHT VS. OBESE 
• Overweight children (defined as ages 6 to 11 years) and 
adolescents (ages 12 to 19 years) are defined as being 
at or above the 85th percentile of Body Mass Index 
(BMI); obese children and adolescents, at or above the 
95th percentile. 
• Some researchers refer to the 95th percentile as over- 
weight, while others refer to it as obese. The Centers 
for Disease Control and Prevention (CDC), which pro- 
vides national statistical data for the weight status of 
American youth, avoids using the word "obesity" and 
identifies every child and adolescent above the 85th 
percentile as "overweight." 
UNITED STATES STATISTICS 
• The percentage of young people who are overweight 
has more than tripled since 1980. 
• Approximately 30.3 percent of children are overweight, 
and 15.3 percent are obese. For adolescents, 30.4 per- 
cent are overweight and 15.5 percent are obese. 
• Sixteen percent (nine million) of children and adoles- 
cents are overweight. 
• Four in 10 Mexican-American and African-American 
children and adolescents are overweight or are at risk 
of being overweight. 
• About sixty percent of obese children ages 5 to 10 
years have at least one cardiovascular disease risk fac- 
tor, including high cholesterol and triglycerides, 
increased insulin levels, or high blood pressure. One 
fourth of these children have two or more risk factors. 
• Children and adolescents who are overweight by the 
age of 8 years are 80 percent more likely to become 
overweight or obese adults. 
• Obesity is the second leading cause of all preventable 
deaths in the United States. 
Information available on these Web sites. 
American Obesity Association: 
www.obesity.org/subs/fastfacts/obesity_youth.shtml. 




Keeping Tabs on 
Multi 
Researchers  are  using Vmagn 
imaging to study myeliri and 
*,py rs^pry Jo Blackwood, RN, MPH 
Multiple sclerosis (MS) is a 
devastating, and as yet, incurable 
autokrfmune disease that affects 
the central nervous system. 
According io the National Multiple 
Sclerosis Society {NMSS), anyone 
can developMS; however, the 
typical candidate is between the 
ages of 20 and 50, a v&man (two 
to three times more often than a 
man), and of Northern European 
descent. About 400,000 Americans 
owledge having MS. Worldwide, 
number may be 2.5 million. 
The exact cause of MS is 
loiQwn but, according to 
researchers, symptoms of MS 
probably are caused by damage to 
the myelin sheath protecting nerves 
and/or by damage to the nerves 
themselves-. Tracking that damage 
is becoming easier because of new 
imaging tecrmjques that can help 
to predict out^cfttie and prognosis, 
as well as to differentiate between 
MS and other 'clinical, less severe 
look-alike^.    *t 
etic   resonance 
nerve damage      -,, 
The NMSS is currently funding 
three studies at Mallinckrodt 
Institute of Radiology that involve 
diffusion tensor imaging (DTI), 
a magnetic resonance imaging 




STRUCTURE OF A TYPICAL NEURON 
measurement of the restricted 
diffusion of water in tissue. DTI's 
principal application is in the 
imaging of white matter where the 
location, orientation, and direc- 
tion of water molecule movement 
can be measured. 
Here, the lead investigators 






Song, an associate professor 
of radiology in the Biomedical Mag- 
netic Resonance Laboratory, has 
a three-year NMSS grant to study 
the use of DTI in differentiating 
between damage to myelin and 
damage to the nerve fibers in 
people with MS. 




Top and middle: a patient with optic neuritis, an early sign of MS. 
Bottom: a model of experimental allergic encephalomyelitis (EAE) 
mimics MS. 
"Based on our work using 
animal models of MS and other 
white matter disease and injury, 
we found that the movement of 
water molecules in nerve fibers is 
a potential marker for nerve injury," 
says Song. "Our research team was 
able to conduct DTI studies on 
nerve fibers from mouse models 
of MS in vivo and confirm our find- 
ings through histological analyses." 
"The current findings suggest 
that this method is capable of 
noninvasively reflecting damages 
to nerve fibers and the protective 
myelin sheath in the animal model," 
he adds. "We want to see if these 
results with animal models can 
translate to patients with optic 
neuritis, an early sign of MS." 
Song is working with groups 
of patients with optic neuritis (an 
early sign of MS that results in tem- 
porary or permanent vision loss) to 
determine if DTI measurements are 
predictive of good and bad recovery. 
In the first study, the correlation of 
DTI results indicating nerve injury 
will be compared to visual function 
in patients with chronic optic 
neuritis. Since myelin 
can regenerate and 
nerves cannot, Song 
is studying both 
patient groups, 
hoping to make a 
correlation between 
nerve damage, myelin 
damage, or both. 
The next study 
will examine patients 
at the onset of optic 
neuritis, and then 
again at three, six, 
and 12 months 
afterwards to track 
changes and to 
determine if poor 
outcomes can be predicted. During 
active optic neuritis, patients with 
and without nerve or myelin dam- 
age will have similar symptoms; 
DTI may give the treating physician 
the currently unavailable information 
on prognosis and treatment stratifi- 
cation. Song also is looking at spinal 
cord damage in patients with MS. 
"It was reported that ninety 
percent of patients with MS have 
spinal cord lesions over the dura- 
tion of the disease," says Song. "In 
a recent study of mouse models of 
MS, our spinal cord DTI analysis 
not only identified the diseased 
animals from the control but also 
correctly differentiated the 
diseased animals with different 
degrees of disabilities. We believe 
that our method will be able to 
predict the severity of disability 
resulting from the spinal cord 
lesions in patients with MS." 
MALLINCKRODT INSTITUTE OF RADIOLOGY 
Joshua Shimony, 
MD, PhD 
"A wonderful property of MRI 
is that the signal can be conditioned 
to produce different types of images," 
says Shimony, an assistant professor 
of radiology and a neuroradiologist. 
"With DTI, the signal can be pro- 
grammed for sensitivity to micro- 
scopic movement of water molecules. 
Diffusion motion is determined by 
a number of factors. Take a bucket 
of water and drop a dot of ink into 
it, and the ink spreads evenly in all 
directions. That's an example of 
unrestricted diffusion." 
"In the brain or other biologic 
tissue, there are many restrictions 
to water movement: proteins, cell 
walls, blood vessels, and the like," 
he adds. "All of these will block 
water from spreading uniformly. " 
^ 
'I 
"Much can be learned from the 
study of MS with DTI, since myelin 
is a major cause of restriction in 
the brain." says Shimony. "Myelin 
forms the insulator around nerve 
fibers and restricts water flow in a 
certain way. As myelin is destroyed, 
the diffusion patterns change, and 
we can see less restriction." 
Axial and coronal views of the restriction of water diffusion in the normal brain. The black-and-white figures show 
where the restriction is highest, mostly in the white matter. In the color figures, the direction of restriction is 
coded by using different colors. 
Shimony keeps up with Song's 
research and looks at different 
aspects of the same problem in his 
NMSS pilot grant to study brain tis- 
sue by using a variation of DTI. 
"Hundreds of scientific papers 
have been written about the results 
from using the DTI model. But, in 
the lab, we have found some limita- 
tions, and there have been some 
variations proposed to describe the 
biology better. My proposal to the 
MS Society is to study a new model 
(which we called the constant- 
offset version of DTI, or DTCO), 
involving patients with mild and 
severe MS as well as patients with 
no disease (called controls), to 
determine whether this model 
is more useful for staging the 
diagnosis. Constant offset was the 
simpest way to change the model 
and has been shown by others in 
our lab to fit the data better," he says. 
DTCO detects water molecules 
that are highly restricted in their 
motion, such as those near a cell 
boundary. Early findings indicate 
this technique may increase the 
ability of DTI to detect differences 
in types of tissue damage. Shimony, 
with the assistance of Larry 
Bretthorst, PhD, a staff scientist in 
the Institute's Biomedical Magnetic 
Resonance Laboratory, developed 
the software to analyze data with 
the new model, and 12 patients 
have already been scanned by 
Shimony's research assistant 
Adrian Epstein. After 15 patients 
(the study's goal) have been 
scanned, Shimony will analyze 
the data and compare it to the data 
from control subjects that have 
been scanned previously. Hopefully, 
the constant-offset model will pro- 
vide new noninvasive ways to view 
different types and amounts of 
tissue damage and tissue recovery; 
all are important in predicting prog- 
nosis and the effect of different 
therapies on the disease. 
"The information gains should 
help to target additional research 
that will further the quest for a 
cure," says Shimony. 
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Patients with MS can have one of four 
forms of the disease. Each form of MS 
can produce mild, moderate, or 
severe symptoms. 
Relapsing-Remitting—Most common (85%). Patients experi- 
ence flare-ups (also called relapses, attacks, or exacerbations). Includes 
episodes of acute worsening of neurological function, followed by par- 
tial or complete recovery (remission). 
Primary-Progressive—Rare (approximately 10%). Patients 
experience slow but continuous worsening of the disease from the 
onset, with no distinct relapses or remissions. Includes variations in 
rates of progression over time, occasional plateaus, and temporary 
minor improvements. 
Secondary-Progressive—Before the availability of "disease- 
modifying" drugs, one half of patients with relapsing-remitting MS 
developed the secondary-progressive form of the disease within 10 
years of their initial diagnosis. Patients experience an initial period of 
relapsing-remitting MS, followed by steadily worsening symptoms 
(with or without occasional flare-ups), minor recoveries (remissions), or 
plateaus. Long-term data are not yet available to demonstrate if devel- 
opment is significantly delayed by treatment. 
Progressive-Relapsing—Rare (approximately 5%). Patients 
experience steadily worsening symptoms from the onset but also have 
clear, acute relapses (attacks or exacerbations), with or without recov- 
ery. The periods between relapses are characterized by continuing dis- 
ease progression. 
Additional information available on the National Multiple Sclerosis Society 
Web site: www.nationalmssociety.org. 
Tammie Benzinger, 
MD, PhD 
Benzinger, an instructor in 
radiology and a neuroradiologist, 
has an NMSS pilot grant to study 
perhaps the most vulnerable 
segment of the MS population: 
children. Although MS is largely an 
adult disease, 2.5 percent of MS 
patients are children—and their 
prognosis is usually more serious. 
Children also are more prone 
to other diseases such as acute 
disseminated encephalomyelitis 
(ADEM), which can be an 
MS look-alike. 
"ADEM can occur after a 
viral or bacterial infection, or even 
after an immunization. It is a self- 
limiting autoimmune response in 
the brain. In children who have 
ADEM, symptoms usually regress 
within three months, even without 
treatment," explains Benzinger. 
"However, those symptoms can 
mimic a chronic debilitating 
disease like MS, which should be 
treated early. A certain number of 
children with ADEM do recover 
but develop MS in adulthood. The 
problem is how to determine injury 
to the nerves versus the reversible 
myelin injury. If patients have 
nerve injury, even if the symptoms 
go away, they seem to be at greater 
risk for MS later." 
"This study is a clinical applica- 
tion of Doctor Song's work with 
the mouse model," she adds. "My 
hypothesis is that the nature of 
the white matter lesions can be 
discriminated between myelin 
injury and axon injury in human 
patients by using DTI as the MR 
biomarker for white matter injury." 
' 
«* 
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The histopathology of 
ADEM and pediatric MS 
are markedly similar: Both 
have demyelination, 
inflammation, and axon 
injury, but in different 
proportions. Even in fatal 
cases, ADEM demyelina- 
tion has limited axon loss 
(nerve injury). However, 
in patients with MS, axon 
loss occurs early in the 
disease—most prominently 
within the first year—so 
early treatment is crucial. 
Benzinger believes that by 
using DTI, physicians could 
differentiate between 
myelin and nerve injury, 
giving a better indication as to 
whether the patient should be 
closely monitored or started on 
aggressive therapy. Current guide- 
lines for MS stress early treatment 
for the best outcomes. 
Her study involves ill children 
during the acute phase of ADEM. 
Up to 20 percent of patients ini- 
tially diagnosed as having ADEM 
are later reclassified as having MS. 
Model of water diffusivity in myelinated axons 
*D- HU>. 
I 
"There are no large studies of 
these children," Benzinger says. 
"I'm collaborating with Doctor Soe 
Mar, from the pediatric neurology 
department at Saint Louis Chil- 
dren's Hospital,who runs a clinic 
for pediatric demyelination. By 
comparing the disease process of 
children diagnosed with ADEM or 
MS and of children who are experi- 
encing a first demyelinating event, 
we hope to determine whether DTI 
"The problem is how to determine injury 
to the nerves versus the reversible 
myelin injury..." 
Study patients initially will undergo 
DTI scanning with a clinical visit 
and will return in six months for 
another scan and visit. Also partici- 
pating in the study are patients 
who were diagnosed up to 15 years 
ago; after they undergo DTI with 
a clinical visit, Benzinger will 
compare their initial and final 
diagnoses. She has identified 90 
potential patients; 12 patients have 
been enrolled in the study. 
results can be useful to diagnose or 
to confirm suspected diagnoses in 
these children." 
Early, accurate differential 
diagnosis of these diseases could 
be critical to children and to their 
families by quickly identifying 
children who could benefit from early 
treatment of MS and sparing those 
with ADEM whose symptoms will 
regress without treatment. 013 
>i-axial = X|| =_1 
X-radial = (_2 + _3)/2 
(decreased with axonal injury) 
(increased with myelin damage) 
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Top: Schematic diagram of spinal cord axons (left) and ellipsoid 
model of water diffusivity within axon bundle (right); both have 
the MRI scanner x, y, and z axes superimposed. 
Middle: Pediatric MS—Axial fluid attenuation inversion recovery 
(FLAIR) image (left) shows multiple lesions. MRI exam (right) shows 
less prominent initial lesions and at least one new lesion (arrow). 
Bottom: Pediatric Multiphasic ADEM—Researchers predict that 
the DTI technique will enable physicians to accurately diagnose 
ADEM and to predict a long-term prognosis. 
RESEARCH STUDY 
• WOULD YOU LIKE TO HELP RESEARCHERS LEARN MORE 
ABOUT MEMORY CAPABILITY IN OLDER ADULTS? 
• DO YOU HAVE A BROTHER OR SISTER WHO IS WITHIN FOUR 
YEARS OF YOUR AGE? 
• ARE YOU OR YOUR SIBLING BETWEEN THE 
AGES OF 70 AND 75? ^^ttfe^ 
Vi olunteers are needed for a Washington University 
School of Medicine/Mallinckrodt Institute of Radiology 
brain imaging study. Both you and your sibling must 
be able to participate in the study Note: if you have had 
a metal device, such as a pacemaker, implanted due to surgery or 
injury, you may not be eligible for the study. 
Eligible volunteers will undergo the following: 
• positron emission tomography (PET) scan 
• magnetic resonance (MR) scan 
• memory assessment 
Volunteers will be compensated for their time and participation. 
FOR MORE INFORMATION, CALL 
314-362-1558. 
F 
this section, the names of employees who are full-time 
rulty or staff or who have an appointment in the 
,'partment of Radiology are highlighted in boldface type. 
IEW FACULTY 
illiam Spees, PhD, 
search instructor in radiol- 




Dione Farria, MD, MPH, 
! assistant professor of radiol- 
ogy, was appointed adjunct 
professor, Department of 
Community Health, Saint 
Louis University School of 
Public Health. 
GRANTS 
Tammie Benzinger, MD, 
PhD, instructor in radiology, 
as principle investigator, 
received a $44,000 pilot 
grant from the National 
Multiple Sclerosis Society 
for her research on "Direc- 
tional diffusivity as an MR 
biomarker in childhood 
demyelinating disease." 
Coinvestigators for the one- 
year grant are Soe Mar, MD, 
Department of Neurology; 
Sheng-Kwei Song, PhD, 
associate professor of radiol- 
ogy; and Anne Cross, MD, 
Department of Neurology. 
Delphine Chen, MD, 
instructor of radiology, as 
principal investigator, 
received a $772,355 grant 
from the National Institutes 
of Health/National Institute 
of Biomedical Imaging and 
Bioengineering to study 
"Apoptosis and inflammation 
imaging." Mentors for the 
five-year grant are Robert 
Mach, PhD, professor of 
radiology and of cell biology 
and physiology; and Mark 
Mintun, MD, professor of 
radiology and of psychiatry. 
She also received a $450,000 
grant from the Damon 
Runyon Cancer Research 
Foundation to investigate 
"Apoptosis imaging." Mentors 
for the three-year Clinical 
Investigator Award are Mach 
and Michael Welch, PhD, 
professor of radiology, of 
chemistry, and of molecular 
biology and pharmacology. 
Nirvikar Dahiya, MD, 
abdominal imaging clinical 
fellow, as principal investiga- 
tor, received a $10,000 Edu- 
cation and Research grant 
from the American Institute 
of Ultrasound in Medicine to 
study "Tendinopathy of the 
rotator cuff: correlation of 
ultrasonographic findings 
with histopathologic 
changes using a cadaver 
shoulder model." 
Igor Efimov, PhD, associate 
professor of biomedical 
engineering and of radiology, 
received a four-year subcon- 
tract in the amount of 
$805,819 from the National 
Institutes of Health to 
investigate "Defibrillation 
mechanisms in infracted 
hearts." As principal investi- 
gator, he received a two- 
year, $143,000 grant-in-aid 
from the American Heart 
Association for research on 
"Structure of the human AV 
junction." 
Dionne Farria, MD, MPH, 
assistant professor of radiol- 
ogy, received a $10,350 STEP 
grant from the St. Louis Affil- 
iate of Susan G. Komen for 
the Cure to study "Reducing 
delays in breast cancer diag- 
nosis in the St. Louis Public 
Safety Net system." Coinves- 
tigators are Katherine Math- 
ews, MD, Department of 
Obstetrics and Gynecology; 
and Susan Kraenzle, RN, 
manager of the Breast 
Health Center at the Alvin 
J. Siteman Cancer Center. 
Jeffrey Lin, MD, PhD, a 
third-year diagnostic radiol- 
ogy resident, received a 
$30,000 seed grant from the 
Radiological Society of 
North America to study 
"Noninvasive characterization 
of NFkB activation in non- 
alcoholic fatty liver disease." 
David Piwnica-Worms, 
MD, PhD, professor of 
radiology and of molecular 
biology and pharmacology, 
is faculty mentor for the 
one-year grant. 
Joel Perlmutter, MD, 
professor of neurology, of 
radiology, and of physical 
therapy, received a National 
Institutes of Health subcon- 
tract of $195,000 to investi- 
gate "Pathophysiology of 
dystonia and parkinsonism." 
The subcontract is through a 
five-year grant awarded to 
Jonathan Mink, MD, Univer- 
sity of Rochester. As princi- 
pal investigator, Perlmutter 
received a one-year, $50,000 
grant from the Huntington 
Disease Society of America 
for his project "Huntington's 
Disease Center of Excellence." 
Joshua Shimony, MD, 
PhD, assistant professor 
of radiology, received a 
$125,000 grant from the 
National Institutes of 
Health/National Institute 
of Child Health and Human 
Development for research on 
"A Bayesian approach to MR 
tractography in the develop- 
ing brain." Coinvestigators 
for the five-year grant are 
Jeffrey Neil, MD, PhD, 
professor of neurology, of 
pediatrics, of neurological 
surgery, and of radiology; 
Terrie Inder, MD, Department 
of Pediatrics; Robert 
McKinstry, MD, PhD, asso- 
ciate professor of radiology; 
and Larry Bretthorst, PhD, 
staff scientist. 
Marilyn Siegel, MD, 
professor of radiology 
and of pediatrics, received 
a $30,000 seed grant from 
the Radiological Society of 
North America for research 
on "Hyperpolarized helium-3 
MRI assessment of bronchi- 
olitis obliterans in pediatric 
lung transplant recipients." 
Collaborators for the one- 
year grant are Dmitriy 
Yablonskiy, PhD, professor 
of radiology and of physics; 
Mark Conradi, PhD, pro- 
fessor of physics, of radiol- 
ogy, and of chemistry; 
David Gierada, MD, associ- 
ate professor of radiology; 
Charles Hildebolt, DDS, 
PhD, associate professor of 
radiology and adjunct 
associate professor of 
anthropology; and Stuart 
Sweet, MD, PhD, Depart- 
ment of Pediatrics. 
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Continued from page 27 
Karen Wooley, PhD, 
professor of chemistry and 
of radiology, received a two- 
year grant of $200,000 (total 
award) from Children's Dis- 
covery Institute, a research 
partnership between St. 
Louis Children's Hospital 
and Washington University 
in St. Louis, for research on 
"Hyperbranched fluoropoly- 
mers (HBFP(III)), designed 
as complex nanostructures 
for imaging and therapeutic 
delivery in the diagnosis and 




William McAlister, MD, 
professor of radiology and of 
pediatrics, was appointed to 
the Board of Directors of the 
Research and Education 
Foundation of the Society 
for Pediatric Radiology. 
Joel Perlmutter, MD, 
professor of neurology, of 
radiology, and of physical 
therapy, was appointed 
cochair of the Mentoring 
Committee for the Parkinson 
Study group. 
Yoram Rudy, PhD, professor 
of engineering, cell biology 
and physiology, and of medi- 
cine, and research professor 
of radiology, was elected to 
a one-year term on the Board 
of Directors for the Interna- 
tional Society for Computer- 
ized Electrocardiology. He 
was elected to a two-year 
term as president of the 
Cardiac Electrophysiology 
Society. 
Karen Wooley, PhD, 
professor of chemistry and 
of radiology, was appointed 
to the editorial advisory 
boards of Bioconjugate 
Chemistry and the Journal 
of the American Chemical 
Society. She was appointed 
to the External Advisory 
Committee of the National 
Science Foundation-Partner- 
ship for Research and 
Education in Materials 
(NSF-PREM) Program with 
the University of California, 
Santa Barbara. She also was 
appointed chair of the 2007 
Polymers (East) Gordon 
Research Conference. 
Pamela Woodard, MD, 
associate professor of 
radiology, was appointed 
to the Editorial Board of 




Yasha Kadkhodayan, MD, 
first-year diagnostic radiology 
resident, received a 2007 
Society of Interventional 
Radiology Resident-in- 
Training Scholarship, which 
funded his attendance at the 
Society's 32"" Annual Scientific 
Meeting in Seattle, Washing- 
ton, March 1-6. 
Jonathan McConathy, MD, 
PhD, a second-year diagnostic 
radiology resident, was one 
of 80 residents nationwide 
chosen to participate in the 
Introduction to Research 
Program at the American 
Roentgen Ray Society's 107"' 
Annual Meeting in Orlando, 
Florida, May 6-11. 
Constantine Raptis, MD, 
a second-year diagnostic 
radiology resident, was one 
of 35 residents in the United 
States selected to attend the 
Siemens-Association of 
University Radiologists 
(AUR) Radiology Resident 
Academic Development 
(SARRAD) Program at the 
AUR's 55°' Annual Meeting in 
Denver, Colorado, April 24-28. 
LECTURES 
Igor Efimov, PhD, associ- 
ate professor of biomedical 
engineering and of radiology, 
presented "New approaches 
to device therapy of cardiac 
arrhythmias: insights from 
optical imaging" at the Bio- 
engineering Leaders Seminar 
Series, sponsored by the 
Department of Biomedical 
Engineering, Duke University, 
Durham, North Carolina, 
January 8. He presented 
"Optical imaging of arrhyth- 
mias" at the University of 
Missouri—St. Louis, January 
12. He spoke on "New 
advances towards painless 
defibrillation" and "Sinoatrial 
and atrioventricular nodal 
structure and function" at 
the Saudi Heart Rhythm 
Society Satellite Symposium, 
the Saudi Heart Association 
XVm Annual Meeting, Jeddah, 
Kingdom of Saudi Arabia, 
February 7. He spoke on 
"New approaches to device 
therapy of cardiac arrhyth- 
mias: insights from optical 
imaging" at the Lillehei Heart 
Institute Grand Rounds, 
University of Minnesota, 
Minneapolis, March 6. 
Dionne Farria, MD, MPH, 
assistant professor of radiol- 
ogy, spoke on "Imaging 
approach to the symptomatic 
breast" and "Imaging evalua- 
tion of breast implants" at 
Women's Health and Imaging 
in a Digital Environment, 
San Antonio, Texas, January 
22. She presented "Screening 
strategies and minority out- 
reach" at the Cancer Centers 
Administrators Forum 
Annual Meeting, St. Louis, 
Missouri, March 26. 
Perry Grigsby, MD, profes- 
sor of radiation oncology 
and of radiology, presented 
"Gynecologic radiation 
oncology: cervical cancer"; 
"Gynecologic radiation 
oncology: endometrial 
cancer"; and "Gynecologic 
radiation oncology: 'How I 
do it' technical aspects of 
gynecologic brachytherapy" 
at the Midwinter Radiation 
Oncology Conference, Los 
Angeles, California, January 
21. As visiting professor, he 
spoke on "Radiotherapy for 
endometrial cancer" and 
"FDG-PET in cervical cancer" 
at Stanford University, Palo 
Alto, California, March 2 and 
3. Grigsby presented "The 
contribution of new imaging 
techniques in staging system"; 
"Multi-modality treatments: 
an update"; "Role of imaging 
Special issues after radiati m 
therapy"; and "Tomotherai >y 
for gynecologic cancers" ai 
the 5"1 International Confei 
ence on Cervical Cancer, 
Venice Lido, Italy, April 13 
18. He presented "IGRT h< vv 
to: pelvis" at the American 
Society for Therapeutic 
Radiology and Oncology 
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] lage Guided Radiotherapy 
i   JRT) Symposium, St. 
tersburg, Florida, April 22. 
■ spoke on "Innovations in 
I achytherapy" at the 28th 
Annual Meeting of the Amer- 
ican Brachytherapy Society, 
( liicago, Illinois, April 28. 
jay Heiken, MD, professor 
uf radiology, as visiting 
professor, spoke on "CT of 
! lie abdominal aorta: diag- 
nosing aneurysm rupture" 
and "Distinguishing benign 
from malignant liver lesions 
with CT and MRI" at the 
Medical College of Wisconsin, 
Milwaukee, January 22. He 
presented "CT colonography 
for colorectal cancer screen- 
ing: current status"; "Benign 
liver masses: detection and 
characterization with CT and 
MRI;" and "Hepatocellular 
carcinoma: imaging evaluation 
with MRI" at Cancer Imaging 
2007, the Joint Meeting of 
the International Cancer 
Imaging Society and the 
Hong Kong College of 
Radiologists, Hong Kong 
SAR, People's Republic of 
China, February 10 and 11. 
Jason Lewis, PhD, assistant 
professor of radiology, 
spoke on "PET imaging of 
cancer with copper-64- 
thiosemicarbazones" at the 
Joint Program in Nuclear 
Medicine, Harvard Medical 
School, Boston, Massachu- 
setts, January 18. 
Robert McKinstry, MD, 
PhD, associate professor 
of radiology, spoke on 
"The triple threat: living the 
dream" at the Harvard- 
Massachusetts Institute of 
Technology Division of 
Health Sciences and Tech- 
nology Alumni Roundtable, 
Boston, Massachusetts, May 1. 
Joel Perlmutter, MD, 
professor of neurology, of 
radiology, and of physical 
therapy, presented "Neu- 
roimaging of Parkinson 
disease progression" at the 
International Society for 
CNS Clinical Trial 
Methodology/Michael J. Fox 
Foundation Meeting on 
Neuroprotective Trials in 
Parkinson Disease, Washing- 
ton, DC, February 11. He 
presented "Mentoring new 
investigators in clinical 
research" and "Neuroimaging 
of Parkinson disease bio- 
markers" to The Parkinson 
Study Group, American 
Academy of Neurology, 
Boston, Massachusetts, 
April 29 and 30. 
Yoram Rudy, PhD, professor 
of engineering, cell biology 
and physiology, and of medi- 
cine, and research professor 
of radiology, presented 
"From genetics to cellular 
function using computational 
biology" to the Center for 
Neurodynamics, Department 
of Physics and Astronomy, 
University of Missouri— 
St. Louis, February 23. He 
spoke on "Computational 
Biello Lecture 
David Townsend, PhD, director of 
the Cancer Imaging and Tracer 
Development Research Program, 
University of Tennessee Medical 
Center, was guest lecturer for the 
21sl Annual Daniel R. Biello Memor- 
ial Lecture on March 14. He spoke 
on "The evolution of PET/CT: a path 
of no return." 
Townsend (left) is shown with Barry Siegel, MD, chief of the Division 
of Nuclear Medicine and coordinator of the Biello Lecture. 
F 
biology and noninvasive 
imaging of cardiac arrhythmia" 
at the Frontiers in Human 
Pathobiology Seminar Series, 
Washington University in 
St. Louis School of Medicine, 
March 7. He spoke on 
"Cardiac Repolarization 
and Arrhythmia: mechanistic 
insights from computational 
biology" at the Cardiovascular 
Research Center, Department 
of Medicine, University of 
Iowa, Iowa City, March 9. He 
presented "Imaging Arrhyth- 
mias in humans: electrocar- 
diographic imaging (ECGI)" 
at the Gordon Research 
Conference on Cardiac 
Arrhythmia Mechanisms, 
Ventura Beach, California, 
March 18. 
Barry Siegel, MD, professor 
of radiology and of medicine, 
spoke on "National Oncologic 
PET Registry (NOPR)," 
"PET/CT of gynecologic 
cancers," and "PET/CT of 
breast cancer" at the First 
Annual PET/CT Update, 
sponsored by the American 
College of Radiology, Boca 
Raton, Florida, January 
28-31. He presented "PET/CT 
in oncology diagnosis'; "Evo- 
lution of PET reimbursement 
and the National Oncologic 
PET Registry': and "PET in 
oncology: beyond FDG" at 
the 22n" Annual Cross-sec- 
tional Imaging Conference, 
sponsored by the University 
of Pennsylvania School of 
Medicine, St. John, U.S. Virgin 
Islands, February 26-March 2. 
He spoke on "National 
Oncologic PET Registry," 
"Update: PET/CT in lung 
cancer," and "Update: 
PET/CT in gynecologic 
malignancies" at Updates 
on PET/CT Imaging for 
Referring Physicians, 
sponsored by Mount Sinai 
School of Medicine, New 
York, New York, April 20. 
FOCAL SPOT, SPRING 2007 29 
LECTURES 
Continued from page 29 
Marilyn Siegel, MD, 
professor of radiology and 
of pediatrics, spoke on 
"Congenital bowel diseases 
in children" and "US/CT of 
acute right lower quadrant 
pain" at the 20lh Japanese 
College of Radiology 
Mid-Winter Seminar, 
Fukuoka, Japan, January 
18-21. She presented "CT of 
the pediatric chest in routine 
practice" and "Vascular 
malformations of the pediatric 
chest" at the 39"' International 
Course on Diagnostic Imaging, 
Davos, Switzerland, March 
24-30. Siegel spoke on 
"Sonography of acute bowel 
disease," "Sonography of 
neonatal hydronephrosis," 
and "Spinal ultrasonography" 
at the 16th Annual Diagnostic 
Ultrasound Symposium, 
Toledo, Ohio, March 10. She 
presented "Pediatric multi- 
slice CT angiography: How I 
do it" at the Society of Pedi- 
atric Radiology Annual Meet- 
ing, Miami, Florida, April 20. 
Yuan-Chuan Tai, PhD, 
assistant professor of radiol- 
ogy, presented "Positron 
emission tomography— 
principles and applications" 
to the Department of Nuclear, 
Plasma, and Radiological 
Engineering, University of 
Illinois at Urbana-Champaign, 
February 6. 
Karen Wooley, PhD, 
professor of chemistry and 
of radiology, presented 
"Complex, amphiphilic 
polymer nanostructures, 
originating from combinations 
of living polymerizations, 
supramolecular assembly 
and regioselective crosslink- 
ing" to the Department of 
Chemistry, Columbia Univer- 
sity, New York, New York, 
February 1. She spoke on 
"The promise of nanotech- 
nology in medicine" at the 
Frontiers in Human Pathobi- 
ology Seminar Series, 
Washington University in 
St. Louis School of Medicine, 
February 14. Wooley spoke 
on "Crafting organic nanos- 
tructures with well-defined 
size, shape, structure and 
properties" at the Chemistry- 
Biology Interface Seminar, 
University of Illinois at 
Urbana-Champaign, March 
12. She presented "Complex 
constructs having nanoscale 
features by combining 
incompatible polymer com- 
ponents" and "Nanoparticles 
and nanocages originating 
from well-defined brush 
block copolymers" at the 
233rd American Chemical 
Society National Meeting & 
Exposition, Chicago, Illinois, 
March 25-29. 
Senturia Lecture 
On May 2, Lane Donnelly, MD, radiologist 
-in-chief at Cincinnati Children's Hospital, 
presented "How to perform and interpret 
MR cine sleep studies for obstructive 
sleep apnea in children" at the 13"' Annual 
Hyman R. Senturia Lecture. 
Pamela Woodard, MD, 
associate professor of radiol- 
ogy, spoke on "Basic cardiac 
MRU and "Delayed contrast- 
enhanced cardiac MRI" at 
the Armed Forces Institute 
of Pathology, Bethesda, 
Maryland, January 22, March 
19, and April 23. 
SYMPOSIA 
In this section ofFYI, only 
those faculty and staff who     m 
have Department of Radiol- 




Robert McKinstry, MD, PhD, chief of pediatric radiology, pre- 
sented Donnelly (right) with a commemorative plaque. 
SOCIETY OF INTERVEN- 
TIONS. RADIOLOGISTS 
32"d Annual Scientific Meeting 
Seattle, Washington 
March 1-6, 2007 
Daniel Brown, MD, work- 
shop coordinator, Gastroin- 
testinal IR: Techniques and 
Management. 
Daniel Picus, MD, panelist, 
Case Based Review: Non- 
Vascular Interventions. 
Suresh Vedantham, MD, 
workshop coordinator, 
Thrombolytic Therapy of 
Venous Thrombolysis. 
James Duncan, MD, PhD; 
Craig Glaiberman, MD; 
Benjamin Jacobs, "Expert 
Performance Evaluation 
Using Real Time Simulated 
Environments: data 
extracted from the 
EXPERTISE protocol." 
James Duncan, MD, PhD: 
Craig Glaiberman, MD, 
"Analysis of simulated angi 
graphic procedures: extraci 
ing efficiency data from 
audio and video recordings 
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Craig Glaiberman, MD; 
James Duncan, MD, PhD, 
"Measuring proficiency 
during renal artery stent 
placement using a high 
fidelity medical simulator." 
Ashesh Parikh, MD; James 
Duncan, MD, PhD; Craig 
Glaiberman, MD, "Record- 
ing datasets for performance 
assessment during medical 
procedures." 
Karun Sharma, MD, PhD; 
Jennifer Gould, MD; 
Daniel Brown, MD, 
"Survivial following hepatic 
arterial chemoembolization 
(HACE) for liver dominant 
melanoma metastases." 
Pamela Woodard, MD, 
"Cardiac CT: non-coronary 
applications." 
SOCIETY OF BREAST 
IMAGING 
<§"' Post Graduate Course 
Hollywood, Florida 
April 14-17, 2007 
REFRESHER COURSE 
)      Dionne Faria, MD, MPH, 
"Work up of masses." 
PANEL DISCUSSION 
\     Barbara Monsees, MD, 
||    "Workflow issues." 
: 
SOCIETY OF GASTROIN- 
TESTINAL RADIOLOGISTS 




Bonita Springs, Florida 
April 15-20, 2007 
IN-CAMERA SESSION 
Jay Heiken, MD, "How can 
we ensure high quality CT 
colonography?" 
PRESENTATION 
Jay Heiken, MD, "Hepatic 
masses: distinguishing 
benign from malignant 
lesions." 
WORKSHOPS 
Dennis Balfe, MD, "ABR 
Update—2007." 
Jay Heiken, MD, "Imaging 
the pancreas: neoplastic and 
inflammatory disease." 
Christine Menias, MD, 
"CT evaluation of lower 
abdominal pain." 
Sharlene Teefey, MD, 
"Ultrasound evaluation of 
TIPS." 
SOCIETY FOR PEDIATRIC 
RADIOLOGY 
50"' Annual Meeting and 
Postgraduate Course 
Miami, Florida 
April 17-21, 2007 
POSTER PRESENTATIONS 
William McAlister, MD, 
"Deactivating germline muta- 
tions in LEMD3 cause 
osteopoikilosis 
and Buschke-Ollendorff syn- 
drome but not melorheosto- 
sis." 
William McAlister, MD, 
"Hypophosphatasia: mislead- 
ing in utero presentation for 
childhood and odonto 
forms."—Award of Honor- 
able Mention 
Prakash Masand, MD; 
Rebecca Hulett Bowling, 
MD, "Multislice CT in 





Prague, Czech Republic 
April 29-May 2, 2007 
SCIENTIFIC PRESENTATIONS 
Robert Gropler, MD, "The 
future of nuclear cardiol- 
ogy"; "Role of nuclear tech- 
niques and hybrids." 
POSTER PRESENTATION 
Pilar Herrero, MS; Donna 
Lesniak, RN; Carmen 
Dence, MS; Zulfia 
Kisrieva-Ware, MD, PhD; 
Robert Gropler, MD, 
"Impact of hyperinsulinemic- 
euglycemicclamp (HIEG) 
during cardiac work on 
myocardial glucose metabo- 
lism, oxidation and glycogen 
formation in type 1 diabetic 
patients." 
INTERNATIONAL SYMPO- 
SIUM ON RADIOPHAR- 
MACEUTICAL SCIENCES 
17th Annual Meeting 
Aachen, Germany 
April 30-May 4, 2007 
KEYNOTE ADDRESS 
Michael Welch, PhD, 
"Thirty years of ISRC: 
changes and consistencies 
with evolving methods and 
targets." 
SCIENTIFIC PRESENTATIONS 
Laura Meyer; Martin 
Eiblmaier; Carolyn 
Anderson, PhD, "Potential 
role of tumor suppressor 
protein p53 in the trafficking 
of copper to the nuclei of 
tumor cells." 
Amy Vavere, PhD; Jason 
Lewis, PhD, "w Cu-labelling 
and small animal PET imaging 
of a Ph-dependent insertion 
peptide-^Cu-DOTA-PHLIP." 
RADIONUCLIDE RESOURCE 
FOR CANCER APPLICATIONS 
AN    NC I - SPONSORED    PROGRAM 
AT   WASHINGTON    UNIVERSITY 
Jason Lewis, PhD; Lucie Tang; and Michael Welch, PhD, of 
Mallinckrodt Institute's Division of Radiological Sciences, were 
the organizers of "Production and Application of 'Non-Standard' 
PET Nuclides"—the April 29th satellite workshop that coin- 
cided with the 17th International Symposium on Radiopharma- 
ceutical Sciences (ISRS) in Aachen, Germany. Presenters at the 
workshop, which was supported by a National Cancer Insti- 
tute/National Institutes of Health grant, discussed the produc- 
tion, use, and dissemination of the "non-standard" PET nuclides. 
More than 100 scientists and engineers from 20 countries 
attended the successful event, which will be offered again in 
2009 at the 18th International ISRS. 
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Raffaella Rossin, PhD; 
Michael Welch, PhD, 
"Small animal PET imaging 
of tumor vasculature using a 
7llBr-labeled human recombi- 
nant anti-ED-B fibronectin 
antibody fragment." 
Aviv Hagooly, PhD; 
Raffaella Rossin, PhD; 
Michael Welch, PhD, 
"Novel nanocarriers for 
imaging and drug delivery: 
in vivo evaluation of 
"Cu-labeled PEG graft 
copolymers." 
POSTER PRESENTATIONS 
Dong Zhou, PhD; Wenhua 
Chu; Justin Rothfuss; 
Lynne Jones; Chenbo 
Zeng; Jinbin Xu; Delphine 
Chen, MD; Michael Welch, 
PhD; Robert Mach, PhD, 
"Radiolabeling and labeling 
mechanism of ['»F]WC-II-89 
for imaging caspase-3 activa- 
tion in apoptosis." 
Carmen Dence, MS; 
Jason Paisley; Sally 
Schwarz, RPh, MS; 
Stephany Shockley; Mark 
Minton, MD; Robert Mach, 
PhD; Michael Welch, PhD, 
"Methodology for the routine 
synthesis of ["C]PK-11195 at 
WUSM." 
Christopher Bognar; 
Gregory Gaehle; Jeffrey 
Willits; Carmen Dence, 
MS; Michael Welch, PhD, 
"Utilizing a versatile inex- 
pensive catalyst 5 robot to 
synthesize [lsF]fluorodihy- 
drotestosterone (,SF-FDHT)." 
Gregory Gaehle; Jeffrey 
Willits; Stephen Moerlein, 
PhD; Robert Mach, PhD; 
Michael Welch, PhD, 
"Automated production of 
[18F]fluorodopa injection, 
USP." 
Thaddeus Wadas; Ashley 
Fiamengo; Christopher 
Sherman; Carolyn Ander- 
son, PhD, "In vivo evalua- 
tion of MCu-labelled 
cross-bridged tetraaza- 
macrocyclic complexes with 
amide and/or carboxylate 
functional groups." 
David Reichert, PhD; 
Jeosong Yoo, "Cyclen-based 
copper complexes as poten- 
tial estrogen receptor lig- 
ands: synthesis, binding 
affinity, and computer 
modeling." 
Wilson Edwards, PhD; 
Samuel Achilefu, PhD; 
Buck Rogers, PhD, "Evalu- 
ation of gene transfer using 
an adenoviral vector encoding 
somatostatin receptor sub- 
type 2 fused to enhanced 
green fluorescent protein." 
Carmen Dence, MS; 
Michael Welch, PhD, 
"Synthesis and in vivo 
characterization of high 
affinity androgens to evaluate 
the role of SHBG in radio- 
steroid delivery." 
Hsiaoju Lee; Michael 
Welch, PhD; Robert Mach, 
PhD, "Developing 18F- 
labeled PPAR gamma antag- 
onists for PET imaging." 
Zhude Tu, PhD; Robert 
Mach, PhD, "Design and 
synthesis of potent and 
selective fluorinated 
dopamine D receptor 
ligands." 
Stephany Shockley; 
Stephen Moerlein, PhD; 
Michael Welch, PhD, 
"Evaluation of the peripheral 
benzodiazepine receptor 
as a marker of proliferation." 
Zhude Tu, PhD; Jinbin Xu; 
Lynne Jones; Delphine 
Chen, MD; Mark Mintun, 
MD; Joel Perlmutter, MD; 
Robert Mach, PhD, 
"Radiosynthesis and in vivo 
and vitro evaluation of an 
18F-labeled radiotracer for 
imaging dopamine D3 recep- 
tors in the CNS." 
Martin Eiblmaier; Richard 
Laforest, PhD; Buck 
Rogers, PhD; Carolyn 
Anderson, PhD, "Internal- 
ization, efflux, and dosimetry 
of two "Cu-labeled somato- 
statin analogs in a human 
SSTr2-transfected cell line." 
Michael Welch, PhD; 
Jason Lewis, PhD, "Synthe- 
sis and characterization of 
"Y-, ^Ga- and lnIn-CHXA 
ReCCMSH(ARGll) 
melanoma targeting peptides." 
Raffaella Rossin; Zhaohui 
Zhou; James Kozlowski; 
Michael Welch, PhD; 
Daniel Schuster, MD, "PET 
imaging of lung endothelium 
with "Cu-labeled targeted 
nanoparticles." 
Amy Vavere, PhD; Jason 
Lewis, PhD, "Diminished 
CU-ATSM hypoxia selectivity 
and its relation to fatty acid 
synthase expression in 
prostate tumors." 
Carmen Dence, MS; 
Richard Laforest, PhD; 
Terry Sharp; Robert 
Mach, PhD; Michael 
Welch, PhD, ""C-methylated 
LY2181308, an antisense 
oligonucleotide to surviving: 




107" Annual Meeting 
Orlando, Florida 
May 6-11, 2007 
Sanjeev Bhalla, MD, 
section chair, Cardiovascular 
Imaging. 
PRESENTATIONS 
Sanjeev BhaUa, MD, 
"Cardiovascular imaging: 
acquired cardiac"; "Pul- 
monary embolic disease"; 
"Nonthromboembolic 
pulmonary embolism." 
Cylen Javidan-Nejad, MD, 
"Cardiovascular imaging: 
congenital." 
Christine Menias, MD, 
"Imaging nontraumatic 
abdominal pain including the 
pregnant patient: CT, MR or 
Ultrasound?" 
Marilyn Siegel, MD, "Pedi 
atric congenital heart disease: 
CTA/MRA and cardiac 
lesions"; "Neonatal neuro- 
sonography." 
Pamela Woodard, MD, 
"First trimester ultrasound 
EXHIBITS 
Prakash Masand, MD, 
"Multislice CT imaging of 
unusual pediatric renal 
masses." 
32 MALLINCKRODT INSTITUTE OF RADIOLOGY 
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lit!lLU       MMfTinjanTTl fflffllnWTnffllTWwjflifil'lKrnTfl 
summer, is a sophisticated bioimaging facility for basic and translational inpatient 
and outpatient clinical research. Investigators in the 9,000-square-foot facility, on 
the 10th floor of Barnes-Jewish Hospital's West Pavilion, will conduct research in 
computed tomography (CT), positron emission tomography (PET), magnetic 
resonance (MR), combined PET/CT, and ultrasound. Shown here is the April 2007 
installation of a massive MR scanner. 
Photograph by Mickey Wynn, MIR Photography Lab. 
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